Isa Iber VD
A Phase 1b/2 Study of the Combination Isatuximab, Iberdomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible or Not Intended for Upfront Transplant
Arms / Cohorts
Experimental:Arm B: Age ≥70 and/or Intermediate Fit/Frail (Reduced-intensity Schedule)
Not yet accepting
Experimental:Arm A: <70 and Fit (Standard-intensity Schedule)
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.